Tajiri, K.; Muraishi, N.; Ishizaka, E.; Murayama, A.; Hayashi, Y.; Yasuda, I.
On-Demand Loco-Regional Treatment for Intrahepatic Lesions Improves Treatment Outcomes in Atezolizumab Plus Bevacizumab Therapy for Unresectable Hepatocellular Carcinoma. Cancers 2026, 18, 1021.
https://doi.org/10.3390/cancers18061021
AMA Style
Tajiri K, Muraishi N, Ishizaka E, Murayama A, Hayashi Y, Yasuda I.
On-Demand Loco-Regional Treatment for Intrahepatic Lesions Improves Treatment Outcomes in Atezolizumab Plus Bevacizumab Therapy for Unresectable Hepatocellular Carcinoma. Cancers. 2026; 18(6):1021.
https://doi.org/10.3390/cancers18061021
Chicago/Turabian Style
Tajiri, Kazuto, Nozomu Muraishi, Eiki Ishizaka, Aiko Murayama, Yuka Hayashi, and Ichiro Yasuda.
2026. "On-Demand Loco-Regional Treatment for Intrahepatic Lesions Improves Treatment Outcomes in Atezolizumab Plus Bevacizumab Therapy for Unresectable Hepatocellular Carcinoma" Cancers 18, no. 6: 1021.
https://doi.org/10.3390/cancers18061021
APA Style
Tajiri, K., Muraishi, N., Ishizaka, E., Murayama, A., Hayashi, Y., & Yasuda, I.
(2026). On-Demand Loco-Regional Treatment for Intrahepatic Lesions Improves Treatment Outcomes in Atezolizumab Plus Bevacizumab Therapy for Unresectable Hepatocellular Carcinoma. Cancers, 18(6), 1021.
https://doi.org/10.3390/cancers18061021